ArticleFrontiers in immunology2025

Targeting FCRLA to induce necrosis in lung adenocarcinoma: a novel strategy for prognosis and therapy via MPT-Driven pathways.

Xiaoli Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.